Clinical Trial Update: Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

View source ↗

Summary

A completed clinical trial analyzing V600 BRAF mutations in participants with metastatic cancers, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Cancers | Status: COMPLETED | Results posted: 2016-04-05